Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-12 av 12

2007
1 Halvorsen, Dag Seeger; Karlsen, Joachim; Notø, Ann-Trude With; Mathiesen, Ellisiv B.; Njølstad, Inger; Gutteberg, tore jarl; Vorland, lars; Hansen, John-Bjarne.
No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques. International Journal of Cardiology 2007 ;Volum 117.
UiT UNN Untitled
 
2005
2 Samuelsen, Ørjan; Haukland, Hanne; Jenssen, Håvard; Kramer, M; Sandvik, K; Ulvatne, Hilde; Vorland, Lars.
Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Letters 2005 ;Volum 579.
HN UiT UNN Untitled
 
3 Samuelsen, Ørjan; Haukland, Hanne; Kahl, BC; Von Eiff, C; Proctor, RA; Ulvatne, H; Sandvik, K; Vorland, Lars.
Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. Journal of Antimicrobial Chemotherapy 2005 ;Volum 56.(6) s. 1126-1129
HN UiT UNN Untitled
 
2004
4 Samuelsen, O; Haukland, Hanne; Ulvatne, H.; Vorland, Lars.
Anti-complement effects of lactoferrin-derived peptides. FEMS Immunology and Medical Microbiology 2004
UiT Untitled
 
5 Ulvatne, H.; Samuelsen, Ørjan; Haukland, Hanne; Kramer, M; Vorland, Lars.
Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiology Letters 2004 ;Volum 237. s. 377-384
UiT UNN Untitled
 
2000
6 Svendsen, John Sigurd; Rekdal, Øystein; Sveinbjørnsson, Baldur; Vorland, Lars.
Bioactive peptides. Patent WO 00/12542 2000
UiT Untitled
 
7 Svendsen, John Sigurd; Rekdal, Øystein; Sveinbjørnsson, Baldur; Vorland, Lars.
Bioactive peptides. Patent WO 00/12541 2000
UiT Untitled
 
1999
8 Rekdal, Øystein; Andersen, Johan Henr; Vorland, Lars; Svendsen, John Sigurd.
The construction and synthesis of lactoferricin derivates with enhanced antibacterial activity. Journal of Peptide Science 1999 ;Volum 5. s. 32-
UiT Untitled
 
9 Vorland, Lars; Osbakk, S. A.; Perstølen, T.; Ulvatne, H.; Rekdal, Øystein; Svendsen, John Sigurd; Gutteberg, Tore Jarl.
Interference of the Anti-microbial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus. Scandinavian Journal of Infectious Diseases 1999 ;Volum 31. s. 173-
UiT Untitled
 
10 Vorland, Lars; Ulvatne, H.; Andersen, Johan Henr; Haukland, Hanne; Rekdal, Øystein; Svendsen, John Sigurd; Gutteberg, Tore Jarl.
Antibacterial effects of lactoferricin B. Scandinavian Journal of Infectious Diseases 1999 ;Volum 31. s. 179-
UiT Untitled
 
11 Vorland, Lars; Ulvatne, H.; Rekdal, Øystein; Svendsen, John Sigurd.
Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scandinavian Journal of Infectious Diseases 1999 ;Volum 31. s. 467-
UiT Untitled
 
1998
12 Vorland, Lars; Ulvatne, H.; Andersen, Johan Henr; Haukland, Hanne; Rekdal, Øystein; Svendsen, John Sigurd; Gutteberg, Tore Jarl.
Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scandinavian Journal of Infectious Diseases 1998
UiT Untitled